ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets

Ma, Jianli; Deng, Yuwei; Zhang, Minghui*; Yu, Jinming*山东大学; 哈尔滨医科大学
Virulence2022-12-31DOI: 10.1080/21505594.2022.2092941
6被引8阅读
引用收藏
分享

摘要

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, has led to more than 170 million confirmed cases in 223 countries and regions, claiming 3,872,457 lives. Some patients with COVID-19 have mild clinical symptoms despite severe respiratory failure, which greatly increases the difficulty of diagnosis and treatment. It is therefore necessary to identify biological characteristics of SARS-CoV-2, screen novel diagnostic and prognostic biomarkers, as well as to explore potential therapeutic targets for COVID-19. In this comprehensive review, we discuss the current published literature on COVID-19. We find that the comprehensive application of genomics, transcriptomics, proteomics and metabolomics is becoming increasingly important in the treatment of COVID-19. Multi-omics analysis platforms are expected to revolutionize the diagnosis and classification of COVID-19. This review aims to provide a reference for diagnosis, surveillance and clinical decision making related to COVID-19.

学科与关键词

关键词
COVID-19multi-omicsgenomicstranscriptomicproteomicsmetabolomics
相关
加载中…
  • Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
    Singh, Rachana; Singh, Pradhyumna Kumar; Kumar, Rajnish*; Kabir, Md. Tanvir; Kamal, Mohammad Amjad; Rauf, Abdur; Albadrani, Ghadeer M.; Sayed, Amany A.; Mousa, Shaker A.; Abdel-Daim, Mohamed M.; Uddin, Md. Sahab*Frontiers in Pharmacology, 2021, 12: 652335.被引 13
  • Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
    Li, Yuming; Hou, Guixue; Zhou, Haibo; Wang, Yanqun; Tun, Hein Min; Zhu, Airu; Zhao, Jingxian; Xiao, Fei; Lin, Shanwen; Liu, Dongdong; Zhou, Dunrong; Mai, Lang; Zhang, Lu; Zhang, Zhaoyong; Kuang, Lijun; Guan, Jiao; Chen, Qiushi; Wen, Liyan; Zhang, Yanjun; Zhuo, Jianfen; Li, Fang; Zhuang, Zhen; Chen, Zhao; Luo, Ling; Liu, Donglan; Chen, Chunke; Gan, Mian; Zhong, Nanshan; Zhao, Jincun*; Ren, Yan*; Xu, Yonghao*Signal Transduction and Targeted Therapy, 2021, 6(1): 155.被引 45
  • Harnessing Deep Learning for Omics in an Era of COVID-19
    Jahanyar, Bahareh; Tabatabaee, Hamid*; Rowhanimanesh, AlirezaOMICS A Journal of Integrative Biology, 2023, 27(4): 141-152.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Virulence
发表日期
2022-12-31
卷期
第 13 卷, 第 1 期
页码
1101-1110
DOI
10.1080/21505594.2022.2092941
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Shandong Cancer Hospital affiliated to Shandong University; Harbin Medical University Cancer Hospital

作者

  • M

    Ma, Jianli (第一作者)

    shandong univ

  • D

    Deng, Yuwei

    harbin med univ

查看全部 4 位作者收起作者
  • Z

    Zhang, Minghui (通讯)

    harbin med univ

  • Y

    Yu, Jinming (通讯)

    shandong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417